Branford, CT, United States of America

Mary A Korpusik


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mary A Korpusik: Innovator in Immunomodulatory Compounds

Introduction

Mary A Korpusik is a notable inventor based in Branford, CT (US). She has made significant contributions to the field of immunology through her innovative research and development of compounds that exhibit immunomodulatory, anti-inflammatory, and anti-proliferative activities. Her work is particularly relevant in the treatment of inflammatory and autoimmune disorders.

Latest Patents

Mary A Korpusik holds a patent for her invention titled "Immunomodulatory, anti-inflammatory, and anti-proliferative compounds." This patent describes compounds that are 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose. These compounds have shown promising results in exhibiting immunomodulatory, anti-inflammatory, and anti-proliferative activity. The patent also discloses methods of preparation, pharmaceutical compositions containing the compounds, and methods for treating inflammatory and/or autoimmune disorders using these compounds.

Career Highlights

Mary is currently associated with Greenwich Pharmaceuticals Incorporated, where she continues to advance her research in the pharmaceutical field. Her work has the potential to impact the treatment of various inflammatory conditions, showcasing her dedication to improving health outcomes through innovative solutions.

Collaborations

Mary has collaborated with esteemed colleagues, including David S Thomson and Thomas P Lawler, III. These collaborations have likely contributed to the depth and breadth of her research, enhancing the development of her patented compounds.

Conclusion

Mary A Korpusik is a pioneering inventor whose work in immunomodulatory compounds is paving the way for new treatments in immunology. Her contributions are significant in addressing inflammatory and autoimmune disorders, and her ongoing research continues to hold promise for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…